FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311857683> ?p ?o ?g. }

• W4311857683 endingPage "7264" @default.
• W4311857683 startingPage "7264" @default.
• W4311857683 abstract "Background: Acute kidney injury (AKI) in critically ill patients is associated with a significant increase in mortality as well as long-term renal dysfunction and chronic kidney disease (CKD). Serum creatinine (SCr), the most widely used biomarker to evaluate kidney function, does not always accurately predict the glomerular filtration rate (GFR), since it is affected by some non-GFR determinants such as muscle mass and recent meat ingestion. Researchers and clinicians have gained interest in cystatin C (CysC), another biomarker of kidney function. The study objective was to compare GFR estimation using SCr and CysC in detecting CKD over a 1-year follow-up after an AKI stage-3 event in the ICU, as well as to analyze the association between eGFR (using SCr and CysC) and mortality after the AKI event. Method: This prospective observational study used the medical records of ICU patients diagnosed with AKI stage 3. SCr and CysC were measured twice during the ICU stay and four times following diagnosis of AKI. The eGFR was calculated using the EKFC equation for SCr and FAS equation for CysC in order to check the prevalence of CKD (defined as eGFR < 60 mL/min/1.73 m2). Results: The study enrolled 101 patients, 36.6% of whom were female, with a median age of 74 years (30−92), and a median length of stay of 14.5 days in intensive care. A significant difference was observed in the estimation of GFR when comparing formulas based on SCrand CysC, resulting in large differences in the prediction of CKD. Three months after the AKI event, eGFRCysC < 25 mL/min/1.73 m2 was a predictive factor of mortality later on; however, this was not the case for eGFRSCr. Conclusion: The incidence of CKD was highly discrepant with eGFRCysC versus eGFRSCr during the follow-up period. CysC detects more CKD events compared to SCr in the follow-up phase and eGFRCysC is a predictor for mortality in follow-up but not eGFRSCr. Determining the proper marker to estimate GFR in the post-ICU period in AKI stage-3 populations needs further study to improve risk stratification." @default.
• W4311857683 created "2023-01-01" @default.
• W4311857683 creator A5007537404 @default.
• W4311857683 creator A5015811382 @default.
• W4311857683 creator A5044903173 @default.
• W4311857683 creator A5056466429 @default.
• W4311857683 creator A5084526485 @default.
• W4311857683 creator A5085757593 @default.
• W4311857683 date "2022-12-07" @default.
• W4311857683 modified "2023-10-18" @default.
• W4311857683 title "Comparison between Cystatin C- and Creatinine-Based Estimated Glomerular Filtration Rate in the Follow-Up of Patients Recovering from a Stage-3 AKI in ICU" @default.
• W4311857683 cites W2036789134 @default.
• W4311857683 cites W2098684703 @default.
• W4311857683 cites W2101752015 @default.
• W4311857683 cites W2123655973 @default.
• W4311857683 cites W2138525207 @default.
• W4311857683 cites W2146081758 @default.
• W4311857683 cites W2151779473 @default.
• W4311857683 cites W2155965977 @default.
• W4311857683 cites W2161086083 @default.
• W4311857683 cites W2163578189 @default.
• W4311857683 cites W2290365562 @default.
• W4311857683 cites W2321777937 @default.
• W4311857683 cites W2576366868 @default.
• W4311857683 cites W2607031541 @default.
• W4311857683 cites W2609684881 @default.
• W4311857683 cites W2611455804 @default.
• W4311857683 cites W2765432216 @default.
• W4311857683 cites W2803690752 @default.
• W4311857683 cites W2888749427 @default.
• W4311857683 cites W2893909320 @default.
• W4311857683 cites W3100457878 @default.
• W4311857683 cites W3112846176 @default.
• W4311857683 cites W3137775641 @default.
• W4311857683 cites W4211157472 @default.
• W4311857683 cites W4226390647 @default.
• W4311857683 cites W98503461 @default.
• W4311857683 doi "https://doi.org/10.3390/jcm11247264" @default.
• W4311857683 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36555881" @default.
• W4311857683 hasPublicationYear "2022" @default.
• W4311857683 type Work @default.
• W4311857683 citedByCount "3" @default.
• W4311857683 countsByYear W43118576832023 @default.
• W4311857683 crossrefType "journal-article" @default.
• W4311857683 hasAuthorship W4311857683A5007537404 @default.
• W4311857683 hasAuthorship W4311857683A5015811382 @default.
• W4311857683 hasAuthorship W4311857683A5044903173 @default.
• W4311857683 hasAuthorship W4311857683A5056466429 @default.
• W4311857683 hasAuthorship W4311857683A5084526485 @default.
• W4311857683 hasAuthorship W4311857683A5085757593 @default.
• W4311857683 hasBestOaLocation W43118576831 @default.
• W4311857683 hasConcept C126322002 @default.
• W4311857683 hasConcept C126894567 @default.
• W4311857683 hasConcept C159641895 @default.
• W4311857683 hasConcept C177713679 @default.
• W4311857683 hasConcept C185592680 @default.
• W4311857683 hasConcept C2776376669 @default.
• W4311857683 hasConcept C2778653478 @default.
• W4311857683 hasConcept C2779541074 @default.
• W4311857683 hasConcept C2779548226 @default.
• W4311857683 hasConcept C2780306776 @default.
• W4311857683 hasConcept C2780472472 @default.
• W4311857683 hasConcept C2781197716 @default.
• W4311857683 hasConcept C55493867 @default.
• W4311857683 hasConcept C71924100 @default.
• W4311857683 hasConceptScore W4311857683C126322002 @default.
• W4311857683 hasConceptScore W4311857683C126894567 @default.
• W4311857683 hasConceptScore W4311857683C159641895 @default.
• W4311857683 hasConceptScore W4311857683C177713679 @default.
• W4311857683 hasConceptScore W4311857683C185592680 @default.
• W4311857683 hasConceptScore W4311857683C2776376669 @default.
• W4311857683 hasConceptScore W4311857683C2778653478 @default.
• W4311857683 hasConceptScore W4311857683C2779541074 @default.
• W4311857683 hasConceptScore W4311857683C2779548226 @default.
• W4311857683 hasConceptScore W4311857683C2780306776 @default.
• W4311857683 hasConceptScore W4311857683C2780472472 @default.
• W4311857683 hasConceptScore W4311857683C2781197716 @default.
• W4311857683 hasConceptScore W4311857683C55493867 @default.
• W4311857683 hasConceptScore W4311857683C71924100 @default.
• W4311857683 hasIssue "24" @default.
• W4311857683 hasLocation W43118576831 @default.
• W4311857683 hasLocation W43118576832 @default.
• W4311857683 hasLocation W43118576833 @default.
• W4311857683 hasLocation W43118576834 @default.
• W4311857683 hasLocation W43118576835 @default.
• W4311857683 hasOpenAccess W4311857683 @default.
• W4311857683 hasPrimaryLocation W43118576831 @default.
• W4311857683 hasRelatedWork W2016525161 @default.
• W4311857683 hasRelatedWork W2032314092 @default.
• W4311857683 hasRelatedWork W2042710484 @default.
• W4311857683 hasRelatedWork W2047016359 @default.
• W4311857683 hasRelatedWork W2098898427 @default.
• W4311857683 hasRelatedWork W2123480441 @default.
• W4311857683 hasRelatedWork W2382476504 @default.
• W4311857683 hasRelatedWork W2968996197 @default.
• W4311857683 hasRelatedWork W2969690374 @default.
• W4311857683 hasRelatedWork W1549458408 @default.
• W4311857683 hasVolume "11" @default.

• next